Correlation Between Chengdu Kanghua and Yili Chuanning
Specify exactly 2 symbols:
By analyzing existing cross correlation between Chengdu Kanghua Biological and Yili Chuanning Biotechnology, you can compare the effects of market volatilities on Chengdu Kanghua and Yili Chuanning and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chengdu Kanghua with a short position of Yili Chuanning. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chengdu Kanghua and Yili Chuanning.
Diversification Opportunities for Chengdu Kanghua and Yili Chuanning
0.84 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Chengdu and Yili is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Chengdu Kanghua Biological and Yili Chuanning Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Yili Chuanning Biote and Chengdu Kanghua is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chengdu Kanghua Biological are associated (or correlated) with Yili Chuanning. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Yili Chuanning Biote has no effect on the direction of Chengdu Kanghua i.e., Chengdu Kanghua and Yili Chuanning go up and down completely randomly.
Pair Corralation between Chengdu Kanghua and Yili Chuanning
Assuming the 90 days trading horizon Chengdu Kanghua is expected to generate 1.26 times less return on investment than Yili Chuanning. In addition to that, Chengdu Kanghua is 1.12 times more volatile than Yili Chuanning Biotechnology. It trades about 0.06 of its total potential returns per unit of risk. Yili Chuanning Biotechnology is currently generating about 0.09 per unit of volatility. If you would invest 1,107 in Yili Chuanning Biotechnology on September 3, 2024 and sell it today you would earn a total of 214.00 from holding Yili Chuanning Biotechnology or generate 19.33% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Chengdu Kanghua Biological vs. Yili Chuanning Biotechnology
Performance |
Timeline |
Chengdu Kanghua Biol |
Yili Chuanning Biote |
Chengdu Kanghua and Yili Chuanning Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Chengdu Kanghua and Yili Chuanning
The main advantage of trading using opposite Chengdu Kanghua and Yili Chuanning positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chengdu Kanghua position performs unexpectedly, Yili Chuanning can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Yili Chuanning will offset losses from the drop in Yili Chuanning's long position.Chengdu Kanghua vs. Chengdu Xinzhu RoadBridge | Chengdu Kanghua vs. China Life Insurance | Chengdu Kanghua vs. Shaanxi Broadcast TV | Chengdu Kanghua vs. Tianshan Aluminum Group |
Yili Chuanning vs. Chengdu Kanghua Biological | Yili Chuanning vs. Beijing Wantai Biological | Yili Chuanning vs. Suzhou Novoprotein Scientific | Yili Chuanning vs. Aluminum Corp of |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
CEOs Directory Screen CEOs from public companies around the world |